102 related articles for article (PubMed ID: 8625256)
1. Increased tubulin acetylation accompanies reversion to stable ploidy in vincristine-resistant CCRF-CEM cells.
Geyp M; Ireland CM; Pittman SM
Cancer Genet Cytogenet; 1996 Apr; 87(2):116-22. PubMed ID: 8625256
[TBL] [Abstract][Full Text] [Related]
2. Resistance to apoptotic cell death in a drug resistant T cell leukaemia cell line.
Geyp M; Ireland CM; Pittman SM
Leukemia; 1996 Mar; 10(3):447-55. PubMed ID: 8642860
[TBL] [Abstract][Full Text] [Related]
3. Karyotypic analysis of CCRF-CEM and drug-resistant cell lines with stable and unstable ploidy.
Pittman SM; Kavallaris M; Stewart BW
Cancer Genet Cytogenet; 1993 Mar; 66(1):54-62. PubMed ID: 8467476
[TBL] [Abstract][Full Text] [Related]
4. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.
Kavallaris M; Tait AS; Walsh BJ; He L; Horwitz SB; Norris MD; Haber M
Cancer Res; 2001 Aug; 61(15):5803-9. PubMed ID: 11479219
[TBL] [Abstract][Full Text] [Related]
5. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
6. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins.
Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC
Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804
[TBL] [Abstract][Full Text] [Related]
7. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
Geley S; Hartmann BL; Hattmannstorfer R; Löffler M; Ausserlechner MJ; Bernhard D; Sgonc R; Strasser-Wozak EM; Ebner M; Auer B; Kofler R
Oncogene; 1997 Nov; 15(20):2429-37. PubMed ID: 9395239
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
Conter V; Beck WT
Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
[TBL] [Abstract][Full Text] [Related]
9. Polymerization of tubulin in apoptotic cells is not cell cycle dependent.
Pittman SM; Strickland D; Ireland CM
Exp Cell Res; 1994 Dec; 215(2):263-72. PubMed ID: 7982469
[TBL] [Abstract][Full Text] [Related]
10. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations.
Verrills NM; Walsh BJ; Cobon GS; Hains PG; Kavallaris M
J Biol Chem; 2003 Nov; 278(46):45082-93. PubMed ID: 12949081
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.
Chumduri C; Gillissen B; Richter A; Richter A; Milojkovic A; Overkamp T; Müller A; Pott C; Daniel PT
J Mol Med (Berl); 2015 May; 93(5):559-72. PubMed ID: 25548804
[TBL] [Abstract][Full Text] [Related]
12. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
13. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
Kavallaris M; Madafiglio J; Norris MD; Haber M
Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
[TBL] [Abstract][Full Text] [Related]
14.
Keenan B; Finol-Urdaneta RK; Hope A; Bremner JB; Kavallaris M; Lucena-Agell D; Oliva MÁ; Díaz JF; Vine KL
Cancer Cell Int; 2020; 20():170. PubMed ID: 32467666
[TBL] [Abstract][Full Text] [Related]
15. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
Avramis IA; Kwock R; Avramis VI
Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
[TBL] [Abstract][Full Text] [Related]
16. [Reversing effect of brassinolide on multidrug resistance of-CCRF-VCR1000 cells and a preliminary investigation on its mechanisms].
Xian LJ; Li YQ; Liu RY; Cao QY; Sun J
Yao Xue Xue Bao; 2005 Feb; 40(2):117-21. PubMed ID: 15875665
[TBL] [Abstract][Full Text] [Related]
17. Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions.
Liaw TY; Salam NK; McKay MJ; Cunningham AM; Hibbs DE; Kavallaris M
Mol Cancer Ther; 2008 Oct; 7(10):3150-9. PubMed ID: 18852118
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.
Kavallaris M; Haber M; Norris MD; Pittman SM; Reed C; Stewart BW
Cancer Lett; 1990 Jun; 51(3):193-201. PubMed ID: 1972035
[TBL] [Abstract][Full Text] [Related]
20. Development and properties of an etoposide-resistant human leukaemic CCRF-CEM cell line.
Patel S; Austin CA; Fisher LM
Anticancer Drug Des; 1990 Feb; 5(1):149-57. PubMed ID: 2156515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
